Indication

Squamous cell carcinoma of head and neck

Squamous cell carcinoma of the head and neck is a malignant neoplasm arising from the mucosal epithelium of the upper aerodigestive tract, including the oral cavity, pharynx, larynx, paranasal sinuses, and nasal cavity. Read more about Squamous cell carcinoma of head and neck

92 drugs 61 manufacturers

Advertisement

Drugs that treat it

Common Squamous cell carcinoma of head and neck therapies.

Showing 82–90 of 92 drugs

DOCETAXEL

ANTINEOPLASTIC - TAXANES·METASTATIC BREAST CARCINOMA·+5
Hospira
Filter & compare in the drug finder →Opens the drug finder with Squamous cell carcinoma of head and neck preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Squamous cell carcinoma of head and neck.

Squamous cell carcinoma of the head and neck is a malignant neoplasm arising from the mucosal epithelium of the upper aerodigestive tract, including the oral cavity, pharynx, larynx, paranasal sinuses, and nasal cavity.

Pathophysiologically, it is characterized by the progressive dysplastic transformation of squamous epithelial cells driven predominantly by chronic exposure to tobacco and alcohol or, particularly in the oropharynx, high-risk human papillomavirus infection.

Patients commonly present with non-healing mucosal ulcerations, persistent dysphagia, odynophagia, hoarseness, or cervical lymphadenopathy, reflecting high rates of locoregional tissue invasion and regional nodal metastasis.

Personalize your experience

Follow Squamous cell carcinoma of head and neck and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it